Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|December 1, 1998
Supplements and Featured Publications
- New Developments in the Treatment of Hypertension: What the HOT Study Means to JNC-VI
- Volume 4
- Issue 13 Suppl
Hypertension in the Older Patient
Author(s)Gary Gerstenblith, MD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Introductionalmost 28 years ago
Barriers to Guideline Adherencealmost 28 years ago
Hypertension in Managed Carealmost 28 years ago
Beta Blockers as First-Line Therapy for Hypertension in the Elderlyalmost 28 years ago
Cost Effectiveness of Intensive Treatment of Hypertensionalmost 28 years ago
Selected Abstractsalmost 28 years ago
CME Quizalmost 28 years ago
BibliographyAdvertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Medigap Plan F enrollment has declined since it was closed to new beneficiaries in 2020. The percentage of individual Medigap enrollees relative to non–dually eligible traditional Medicare beneficiaries increased from 2013-2024.
Among the therapeutic alternatives used in Medicare’s drug price negotiations, many were generics or biosimilars, and most differed in mechanistic class from the negotiated drug.
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
3
EEOC Reportedly Plans to Narrow Pregnancy Accommodation Rules
4
Data Show Upadacitinib Repigments Skin in Nonsegmental Vitiligo
5